Third, input on cost data was taken from a Calgary study and there might be significant cost differences for managing DM-ESRD patients between Alberta and Saskatchewan.
← all excerpts
Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.
1
—
—